Advertisement

Topics

Search Results for "Calcifications In The Prostate Gland"

17:06 EDT 27th July 2016 | BioPortfolio

Matching Channels

Prostate Cancer in Men

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or ...

Prostate Mab

Salivary Gland Tumors

Bartholin's Gland Cysts

Malignant salivary gland tumors

Matching News

The role of the prostate in male fertility, health and disease

The prostate gland is the major male reproductive gland involved in male fertility. In this Review, the authors discuss the reproductive function of the prostate gland, summarizing physiological and m...

UPDATE 1-Shanghai Fosun says it has made a non-binding bid for India's Gland Pharma

* Gland, maker of injectable drugs, is backed by KKR (Add other suitors for Gland)

New form of SBRT to deliver radiation to specific area of prostate cancer

University Hospitals Seidman Cancer Center physicians have started the world's first clinical trial using a new form of stereotactic body radiotherapy (SBRT) to deliver radiation to a specific area of...

BPA changes foetal development of the mammary gland and can raise breast cancer risk

A new culture system that tests the role of chemical exposure on the developing mammary gland has found that bisphenol A (BPA) directly affects the mammary gland of mouse embryos. The study results, ...

Enzo Life Sciences Total PSA (human) ELISA kit

Prostate-specific antigen (PSA), also known as γ-seminoprotein or kallikrein-3 (KLK3), is a kallikrein-like protease produced by the epithelial cells in the prostate gland, the lining of the urethra ...

Meibomian Gland Dysfunction: Hyperkeratinization or Atrophy?

In this review, the authors examine the latest evidence on the roles of gland atrophy and ductal hyperkeratinization in the development of meibomian gland dysfunction. BMC Ophthalmology

UH Seidman Cancer Center first in the world to apply SBRT

(University Hospitals Case Medical Center) University Hospitals Seidman Cancer Center physicians have started the world's first clinical trial using a new form of stereotactic body radiotherapy (SBRT)...

What you need to know about an elevated PSA

NEW YORK, Feb. 23, 2016 /PRNewswire/ -- As men get older, they should be aware of their PSA, whether it is elevated, and what it means for the PSA to be elevated. PSA stands for prostate-specific...

Matching PubMed Articles

Prostate cancer.

Essential facts Prostate cancer starts in the prostate gland, at the base of the bladder in men. It surrounds the first part of the urethra, which carries urine from the bladder. The prostate gland he...

Hoxb13, a potential prognostic biomarker for prostate cancer.

HOXB13, a member of the homeobox proteins family, is a key regulator of the epithelial differentiation in the prostate gland. HOXB13 is overexpressed during malignant progression of the prostatic tiss...

Clinical significance of incidental FDG uptake in the prostate gland detected by PET/CT.

The value of FDG-positron emission tomography/computed tomography (PET/CT) for detecting prostate cancer is unknown. We aimed to investigate the clinical value of incidental prostate FDG uptake on PET...

Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01.

To estimate the contribution of the prostate gland and prostatic urethral inflammation to urinary symptoms after radiation therapy for prostate cancer, we performed a secondary analysis of urinary tox...

Multivariable model development and internal validation for prostate cancer specific survival and overall survival after whole-gland salvage Iodine-125 prostate brachytherapy.

Whole-gland salvage Iodine-125-brachytherapy is a potentially curative treatment strategy for localised prostate cancer (PCa) recurrences after radiotherapy. Prognostic factors influencing PCa-specifi...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement